Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update

Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39:1073–8. Araque-Calderon Y, Miranda-Contreras L, Rodriguez-Lemoine V, Palacios-Pru EL. Antibiotic resistance patterns and SDS-PAGE protein profiles of Burkholderia cepacia complex isolates from nosocomial and environmental sources in Venezuela. Med Sci Monit. 2008;14(2):BR49–55. Gautam V, Ray P, Vandamme P, Chatterjee SS, Das A, Sharma K, et al. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex). Indian J Med Microbiol. 2009;27(2):128–33. Gautam V, Singh M, Singhal L, Kaur M, Kumar A, Ray P. Burkholderia cepacia complex in Indian cystic fibrosis patients. Indian J Med Res. 2012;136(5):882–3. Burkholder WH. Sour skin, a bacterial rot of onion bulbs. Phytopathology. 1950;40:115–7. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia Palleroni and Holmes 1981 comb. nov. Microbiol Immunol. 1992;36(12):1251–75. Yabuuchi E, Kosako Y, Yano I, Hotta H, Nishiuchi Y. Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff, comb nov, Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov. Microbiol. Immunol. 1973;1995(39):897–904. Coenye T, Vandamme P. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol. 2003;5(9):719–29. Coenye T, Vandamme P, Govan JR, Lipuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39(10):3427–36. Kiska DL, Kerr A, Jones MC, Caracciolo JA, Eskridge B, Jordan M, Miller S, Hughes D, King N, Gilligan P. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative, nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol. 1996;34:886–91. Larsen GY, Stull TL, Burns JL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol. 1993;31:788–92. Liu PYF, Dhi ZY, Lau YJ, Hu BS, Shyr JM, Tsai WS, Lin YH, Tseng CY. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol. 1995;33:3304–7. Simpson IN, Finlay J, Winstanley DJ, Dehwurst N, Nelson JW, Butler SL, Govan JRW. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother. 1994;34:353–61. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, Govan JRW. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997;47:1188–200. Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroucke K, Gillis M, Speert DP, Vandamme P. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol. 2001;51:271–9. Coenye T, Mahenthiralingam E, Henry D, LiPuma JJ, Laevens S, Gillis M, Speert DP. Vandamme P. Burkholderia ambifaria sp. nov, a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol. 2001;51:1481–90. Balandreau J, Viallard V, Cournoyer B, Coenye T, Laevens S, Vandamme P. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol. 2001;67:982–5. Coenye T, Holmes B, Kersters K, Govan JRW, Vandamme P. Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior subjective synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively. Int J Syst Bacteriol. 1999;49:37–42. Coenye T, Schouls LM, Govan JRW, Kersters K, Vandamme P. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int J Syst Bacteriol. 1999;49:1657–66. Gillis M, Van Van T, Bardin R, Goor M, Hebbar P, Willems A, Segers P, Kersters K, Heulin T, Fernandez MP. Polyphasic taxonomy in the genus Burkholderia leading to an emended description of the genus and proposition of Burkholderia vietnamiensis sp nov for N2- fixing isolates from rice in Vietnam. Int J Syst Bacteriol. 1995;45:274–89. Gilligan PH, Gage PA, Bradshaw LM, Schidlow DV, DeCicco BT. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985;22:5–8. Welch DF, Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PG, Hilman BC, Chartrand SA. Selective and differential medium for the recovery of Pseudomonas cepacia from the respiratory tract of patients with cystic fibrosis. J Clin Microbiol. 1987;25:1730–4. Henry DA, Campbell ME, LiPuma JJ, Speert DP. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol. 1997;35:614–9. Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1999;37:1004–7. Fehlberg LCC, Lucas Henrique Sales Andrade, Diego Magno Assis, Rosana Helena Vicente Pereira, Ana Cristina Gales, Elizabeth Andrade Marques. Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates. Diagn Microbiol Infect Dis. 2013;77:126–8. Jones AM, Dodd ME, Govan JR, Barcus V, Doherty CJ, Morris J, et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax. 2004;59(11):948–51. Antony B, Cherian EV, Boloor R, Shenoy KV. A sporadic outbreak of Burkholderia cepacia complex bacteremia in pediatric intensive care unit of a tertiary care hospital in coastal Karnataka. South India. Indian J Pathol Microbiol. 2016;59:197–9. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol. 2005;3:144–56. Reik R, Spilker T, Lipuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol. 2005;43:2926–8. Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, et al. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol. 2012;50(6):2034–9. Alby K, Gilligan PH, Miller MB. Comparison of Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry Platforms for the Identification of Gram-Negative Rods from Patients with Cystic Fibrosis. J Clin Microbiol. 2013;51(11):3852–4. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, et al. Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2014;33(3):337–46. Plongla R, Panagea T, Pincus DH, Jones MC, Gilligan PH. Identification of Burkholderia and uncommon glucose non-fermenting Gram-negative Bacilli isolated from patients with cystic fibrosis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). J Clin Microbiol. 2016;54(12):3071–2. Gautam V, Sharma M, Singhal L, Kumar S, Kaur P, Tiwari R, Ray P. MALDI-TOF mass spectrometry: an emerging tool for unequivocal identification of non-fermenting Gram-negative bacilli. Indian J Med Res. 2017;145(5):665–72. Stryjewski ME, LiPuma JJ, Messier RH, Reller LB, Alexander BD. Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. J Clin Microbiol. 2003;41(5):2255–7. Jørgensen IM, Johansen HK, Frederiksen B, Pressler T, Hansen A, Vandamme P, et al. Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol. 2003;36:439–46. Atkinson RM, LiPuma JJ, Rosenbluth DB, Dunne WM. Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR. J Clin Microbiol. 2006;44:833–6. Pimentel JD, MacLeod C. Misidentification of Pandoraea sputorum isolated from sputum of a patient with cystic fibrosis and review of Pandoraea species infections in transplant patients. J Clin Microbiol. 2008;46(9):3165–8. Caraher E, Collins J, Herbert G, Murphy PG, Gallagher CG, Crowe MJ, et al. Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithelial cells. J Med Microbiol. 2008;57:15–20. Martina PF, Martínez M, Frada G, Alvarez F, Leguizamón L, Prieto C, et al. First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case report. BMC Pulm Med. 2017;17:33. Ryan MP, Pembroke JT, Adley CC. Ralstonia pickettii: a persistent Gram-negative nosocomial infectious organism. J Hosp Infect. 2006;62:278–84. Waugh JB, Granger WM, Gaggar A. Incidence, relevance and response for Ralstonia respiratory infections. Clin Lab Sci. 2010;23(2):99–106. Orme J, Rivera-Bonilla T, Loli A, Blattman NN. Native valve endocarditis due to Ralstonia pickettii: a case report and literature review. Case Rep Infect Dis. 2015;2015:324675. Lai HW, Shen YH, Chien LJ, Tseng SH, Mu JJ, Chan YJ, et al. Outbreak of Ralstonia pickettii bacteremia caused by contaminated saline solution in Taiwan. Am J Infect Control. 2016;44(10):1191–2. Papaleo MC, Perrin E, Maida I, Fondi M, Fani R, Vandamme P. Identification of species of the Burkholderia cepacia complex by sequence analysis of the hisA gene. J Med Microbiol. 2010;59(10):1163–70. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165–73. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997;47:1188–200. Frickmann H, Neubauer H, Loderstaedt U, Derschum H, Hagen RM. rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp). 2014;4(2):106–16. Ginther JL, Mayo M, Warrington SD, Kaestli M, Mullins T, Wagner DM, et al. Identification of Burkholderia pseudomallei near-neighbor species in the northern territory of Australia. PLoS Negl Trop Dis. 2000;9(6):e0003892. Vandamme P, Pot B, Gillis M, de Vos P, Kersters K, Swings J. Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev. 1996;60:407–38. Suarez-Moreno ZR, Devescovi G, Myers M, Hallack L, Mendonca-Previato L, Caballero-Mellado J, et al. Commonalities and differences in regulation of N-acyl homoserine lactone quorum sensing in the beneficial plant-associated Burkholderia species cluster. Appl Environ Microbiol. 2010;76(13):4302–17. Guglierame P, Pasca MR, De Rossi E, Buroni S, Arrigo P, Manina G, Riccardi G. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol. 2006;6:66. https://doi.org/10.1186/1471-2180-6-66. Tseng SP, Tsai WC, Liang CY, Lin YS, Huang JW, Chang CY, Tyan YC, Lu PL. The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity. PLoS ONE. 2014;9:e104986. https://doi.org/10.1371/journal.pone.0104986. Podnecky NL, Rhodes KA, Schweizer HP. Efflux pump-mediated drug resistance in Burkholderia. Front Microbiol. 2015;6:305. https://doi.org/10.3389/fmicb.2015.00305. Bazzini S, Udine C, Sass A, Pasca MR, Longo F, Emiliani G, Fondi M, Perrin E, Decorosi F, Viti C, Giovannetti L, Leoni L, Fani R, Riccardi G, Mahenthiralingam E, Buroni S. Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS ONE. 2011;6:e18902. https://doi.org/10.1371/journal.pone.0018902. Buroni S, Matthijs N, Spadaro F, Van Acker H, Scoffone VC, Pasca MR, Riccardi G, Coenye T. Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells. Antimicrob Agents Chemother. 2014;58:7424–9. https://doi.org/10.1128/AAC.03800-14. Trepanier S, Prince A, Huletzky A. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob Agents Chemother. 1997;41:2399–405. Hwang J, Kim HS. Cell wall recycling-linked coregulation of AmpC and PenB beta-lactamases through ampD mutations in Burkholderia cenocepacia. Antimicrob Agents Chemother. 2015;59:7602–10. Vadlamani G, Thomas MD, Patel TR, Donald LJ, Reeve TM, Stetefeld J, Standing KG, Vocadlo DJ, Mark BL. The beta-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide. J Biol Chem. 2015;290:2630–43. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, Brinkman FSL. The Burkholderia genome database: facilitating flexible queries and comparative analyses. Bioinformatics. 2008;24:2803–4. Poirel L, Rodriguez-Martinez JM, Plesiat P, Nordmann P. Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex. Antimicrob Agents Chemother. 2009;53:876–82. Papp-Wallace KM, Taracila MA, Gatta JA, Ohuchi N, Bonomo RA, Nukaga M. Insights into beta-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. J Biol Chem. 2013;288:19090–102. Rhodes Katherine A, Schweizer Herbert P. Antibiotic resistance in Burkholderia species. Drug Resist Updat. 2016;28:82–90. Gautam V, Shafiq N, Singh M, Ray P, Singhal L, Jaiswal NP, Prasad A, Singh S, Agarwal A. Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections. Expert Rev Anti Infect Ther. 2015;13(5):629–63. Pegues DA. Burkholderia cepacia complex. http://www.antimicrobe.org/b19.asp. Nimri L, Sulaiman M, Hani OB. Community-acquired urinary tract infections caused by Burkholderia cepacia complex in patients with no underlying risk factor. JMM Case Rep. 2017;4(1):e005081. Blumer JL, Saiman L, Konstan MW, Melnick D. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Chest. 2005;128(4):2336–46. Bonacorsi S, Fitoussi F, Lhopital S, Bingen E. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 1999;43(2):213–7. Aaron SD, Ferris W, Henry DA, et al. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1206–12. Saiman L, Chen Y, Gabriel PS, Knirsch C. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother. 2002;46(4):1105–7. MacLeod DL, Barker LM, Sutherland JL, et al. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother. 2009;64(4):829–36.